600,000 People Set to Receive Twice-Yearly HIV Prevention Injection by End of 2026 as Global Access Drive Accelerates
By Michael Gwarisa in RIO DE JANEIRO An estimated 600,000 people are expected to be receiving the groundbreaking twice-yearly HIV prevention injection lenacapavir by the end of 2026, with the number projected to surpass one million early next year, as global efforts to rapidly expand access to long-acting HIV prevention gather pace. The milestone was
Read More
Zimbabwe Advances Community Pharmacy Model to Expand Access to PrEP, Including Lenacapavir
By Michael Gwarisa RIO DE JANEIRO, Brazil – Zimbabwe is testing an innovative public-private partnership that could transform HIV prevention by integrating community pharmacies into the delivery of pre-exposure prophylaxis (PrEP), including long-acting lenacapavir, as the country seeks to make HIV prevention services more accessible and convenient for communities. Presenting the initiative at the 26th
Read More
Registration Opens for Cimas Healthathon 3.0 as Innovators Race to Transform Healthcare
By Staff Reporter Cimas Health Group has opened registration for Cimas Healthathon 3.0, inviting innovators across Zimbabwe to develop practical, technology-driven solutions aimed at improving healthcare access, affordability and service delivery. Running under the theme “Reimagining Healthcare Through Disruptive Innovation,” the challenge targets innovation hubs, start-ups, university technology teams, software developers and product innovators. Participants
Read More
Zimbabwean Innovators to Compete for US$7,000 in Cimas Healthathon 3.0
Michael Gwarisa Cimas Health Group has launched the third edition of its national Healthathon competition, inviting innovators, startups and university technology teams to develop digital solutions capable of transforming healthcare delivery in Zimbabwe. Speaking at the launch held at the Cimas Health Group headquarters in Borrowdale, Harare, on Wednesday, Chief Executive Officer Mr Vuli Ndlovu
Read More
Nucleic Acid Testing Technology Expands Blood Collection Frontiers, Boosts Zimbabwe’s Blood Stocks
Michael Gwarisa …National Blood Service Zimbabwe scales up collection target to nearly 90,000 units as NAT enhances safety and access to new donor sites The commissioning of the Nucleic Acid Testing (NAT) machine at the National Blood Service Zimbabwe (NBSZ) in early 2026 has significantly transformed blood collection operations, enabling the national blood bank to
Read More
Zimbabwe Becomes Southern Africa’s Second Nation to Offer Neuromodulation Surgery
Kuda Pembere Zimbabwe has become only the second country in Southern Africa, after South Africa, to offer neuromodulation surgery, a major milestone in the country’s efforts to provide advanced specialist healthcare services locally and reduce the need for patients to seek treatment abroad. The breakthrough follows a partnership involving Zimbabwe’s Ministry of Health and Child
Read More
For Years They Woke Up to Ash and Smoke. Mpilo’s New Incinerator Changed That
Michael Gwarisa in Bulawayo For years, families living near Mpilo Central Hospital woke up to the same reality: ash settling on rooftops and washing lines, thick smoke hanging in the air, and fumes so harsh they sometimes forced residents indoors. Today, many say that has changed. A newly constructed high-capacity medical waste incinerator, built under
Read More
Three Minutes to a Diagnosis: How Digital X-Rays Are Transforming Rural Healthcare
Michael Gwarisa in Manicaland Despite the scorching heat, 58-year-old Fibion Nyatsanza (Not his real name), from Saumani village in the Honde Valley is determined to find out what has been keeping him awake at night for the past three weeks. Shortly after midday, he walks through the gates of Hauna District Hospital, clad in a
Read More
Merck Once-Daily ARV Pill Could Reach Market Soon
Michael Gwarisa In a move that could significantly reduce pill burden and improve adherence to antiretroviral therapy (ART), the United States Food and Drug Administration has approved a new once-daily pill developed by Merck & Co. for adults living with HIV-1 who are already virologically suppressed. The pill is intended to replace a patient’s existing
Read More
Zimbabwean Company Launches Drone Technology to Deliver Medicines and Blood Products
Michael Gwarisa Drone Solutions, a local logistics company, has introduced drone technology to deliver medicines, blood and blood products, among other essential health commodities, across Zimbabwe. The move is set to address gaps in the healthcare supply chain while tackling persistent challenges such as poor road networks and transport-related delays. It is also expected to
Read More